PortfoliosLab logoPortfoliosLab logo
IPO Date
Mar 20, 2012

Highlights

Market Cap
$91.37M
Enterprise Value
$109.89M
EPS (TTM)
$0.02
PE Ratio
50.44
Total Revenue (TTM)
$62.06M
Gross Profit (TTM)
$16.06M
EBITDA (TTM)
$3.48M
Year Range
$0.78 - $5.63
ROA (TTM)
3.58%
ROE (TTM)
10.15%

Share Price Chart


Loading charts...

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Solesence, Inc

Performance

SLSN Performance Chart

Solesence, Inc (SLSN) is down 21.3% since the beginning of the year. At $1 per share, SLSN is trading 77.7% below its 52-week high of $6. Investors who bought $1,000 worth of SLSN shares 5 years ago would now be looking at an investment worth $730.


Loading charts...

S&P 500 Index

Returns By Period

Solesence, Inc (SLSN) has returned -21.32% so far this year and -69.90% over the past 12 months. Over the last ten years, SLSN has returned 9.21% per year, falling short of the S&P 500 Index benchmark, which averaged 13.66% annually.


Solesence, Inc

1D
-9.71%
1M
-2.33%
YTD
-21.32%
6M
-40.80%
1Y
-69.90%
3Y*
-3.58%
5Y*
-6.11%
10Y*
9.21%

Benchmark (S&P 500 Index)

1D
-0.74%
1M
4.90%
YTD
10.35%
6M
10.28%
1Y
26.52%
3Y*
20.83%
5Y*
12.30%
10Y*
13.66%
*Multi-year figures are annualized to reflect compound growth (CAGR)

SLSN Monthly Returns History

Based on dividend-adjusted daily data since Mar 20, 2012, SLSN's average daily return is +0.27%, while the average monthly return is +3.14%. At this rate, an investment would double in approximately 1.9 years.

Historically, 51% of months were positive and 49% were negative. The best month was Apr 2018 with a return of +141.3%, while the worst month was Mar 2020 at -40.0%. The longest winning streak lasted 9 consecutive months, and the longest losing streak was 7 months.

On a daily basis, SLSN closed higher 39% of trading days. The best single day was Apr 29, 2020 with a return of +81.0%, while the worst single day was May 6, 2020 at -34.7%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2026-15.36%-5.19%-25.89%41.26%-8.21%2.03%-21.32%
202520.34%-3.74%-27.56%51.22%24.52%12.95%-21.33%6.71%-12.02%1.55%-29.97%-30.35%-34.71%
2024-12.50%61.43%-17.29%92.58%18.52%-3.12%0.00%-4.90%10.12%15.82%44.68%-10.18%307.17%
2023-2.65%30.00%-10.49%-26.60%27.73%16.13%-6.72%-21.92%-13.79%-1.13%-13.31%-20.00%-46.90%
2022-32.95%14.92%9.14%-25.68%16.36%-7.50%4.05%-11.04%-13.50%0.21%-34.32%-27.56%-74.32%
20217.65%8.20%22.22%33.06%-2.48%7.01%43.15%0.00%13.93%16.79%24.53%10.41%417.65%

Benchmark Metrics

Solesence, Inc has an annualized alpha of 89.73%, beta of 0.32, and R2 of 0.00 versus S&P 500 Index. Calculated based on daily prices since March 21, 2012.

  • This stock participated in 85.79% of S&P 500 Index downside but only 84.64% of its upside - more exposed to losses than it benefited from rallies.
  • Beta of 0.32 may look defensive, but with R2 of 0.00 this stock is largely uncorrelated with S&P 500 Index - low beta reflects independence, not downside protection. See the Volatility section for a true picture of this stock's risk.
  • R2 of 0.00 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

Alpha
89.73%
Beta
0.32
0.00
Upside Capture
84.64%
Downside Capture
85.79%

Return for Risk

Risk / Return Rank

SLSN ranks 13 for risk / return — in the bottom 13% of stocks on our site. This means you're taking on significantly more risk than the returns justify. Consider whether the potential upside is worth the volatility, or explore alternatives with better risk / return profiles.


SLSN Risk / Return Rank: 1313
Overall Rank
SLSN Sharpe Ratio Rank: 1313
Sharpe Ratio Rank
SLSN Sortino Ratio Rank: 1212
Sortino Ratio Rank
SLSN Omega Ratio Rank: 1414
Omega Ratio Rank
SLSN Calmar Ratio Rank: 1010
Calmar Ratio Rank
SLSN Martin Ratio Rank: 1414
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

Return / Risk — by metrics

The table below present risk-adjusted performance metrics for Solesence, Inc (SLSN) and compare them to S&P 500 Index.


SLSNBenchmarkDifference

Sharpe ratio

Return per unit of total volatility

-0.68

2.24

-2.92

Sortino ratio

Return per unit of downside risk

-0.95

3.07

-4.03

Omega ratio

Gain probability vs. loss probability

0.89

1.41

-0.51

Calmar ratio

Return relative to maximum drawdown

-0.83

2.93

-3.76

Martin ratio

Return relative to average drawdown

-1.21

13.52

-14.74

Dividends

Dividend History


Solesence, Inc doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading charts...

Worst Drawdowns

The table below displays the maximum drawdowns of the Solesence, Inc. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Solesence, Inc was 90.27%, occurring on Jan 23, 2024. Recovery took 352 trading sessions.

The current Solesence, Inc drawdown is 75.91%.


Related event

Drawdown

Fall

Recovery

Underwater

2024 bear market2024
-90.27%Jan 2024
2y 18d1y 4mo
3y 5moJan 2022 - Jun 2025
COVID crash2020
-86.61%Apr 2020
1y 11mo11mo 24d
2y 11moApr 2018 - Apr 2021
2026 bear market2026
-84.44%Mar 2026
8mo 28d
11mo 16dJun 2025 - now
2012 bear market2012
-52.60%Nov 2012
6mo 21d6mo 27d
1y 1moApr 2012 - May 2013
2018 bear market2018
-51.19%Jan 2018
1y 5mo2mo 19d
1y 8moAug 2016 - Apr 2018

Drawdown Indicators


SLSNBenchmarkDifference

Max Drawdown

Largest peak-to-trough decline

-90.27%

-56.78%

-33.49%

Max Drawdown (1Y)

Largest decline over 1 year

-84.44%

-9.10%

-75.34%

Max Drawdown (3Y)

Largest decline over 3 years

-84.44%

-18.90%

-65.54%

Max Drawdown (5Y)

Largest decline over 5 years

-90.27%

-25.43%

-64.84%

Max Drawdown (10Y)

Largest decline over 10 years

-90.27%

-33.92%

-56.35%

Current Drawdown

Current decline from peak

-75.91%

-0.74%

-75.17%

Average Drawdown

Average peak-to-trough decline

-38.87%

-10.72%

-28.15%

Ulcer Index

Depth and duration of drawdowns from previous peaks

57.56%

1.97%

+55.59%

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading charts...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Solesence, Inc over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how Solesence, Inc is priced in the market compared to other companies in the Household & Personal Products industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PE Ratio

The chart displays the Price-to-Earnings (P/E) ratio for SLSN, comparing it with other companies in the Household & Personal Products industry. Currently, SLSN has a P/E ratio of 50.4. This P/E ratio is significantly higher than those of industry peers. This could indicate that the stock is overvalued or that investors expect strong future growth.

PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for SLSN relative to other companies in the Household & Personal Products industry. Currently, SLSN has a P/S ratio of 1.5. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.

PB Ratio

The chart illustrates the Price-to-Book (P/B) ratio for SLSN in comparison with other companies in the Household & Personal Products industry. Currently, SLSN has a P/B value of 5.2. This P/B ratio is higher than most companies in the industry. It may suggest the stock is overvalued or that investors expect the company to generate high returns on its assets.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items
Portfolio Analyzer

Build a portfolio with SLSN

Add Solesence, Inc to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Analyzer with SLSN